| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8d0fc2b70675ee19bd5fc464f5ae9061 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K48-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-16 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K48-00 |
| filingDate |
2008-05-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e842e588cedf8a5a8f7aa410e0294f10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_18a14ef50ce398a3d0b4152eab8154c4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_edb361d124293740cfdeb1c668ec5055 |
| publicationDate |
2009-11-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
KR-20090116955-A |
| titleOfInvention |
NMD regulation method using gene PNCR2 |
| abstract |
The present invention provides a gene PNRC2 that can control nonsense-mediated mRNA disruption (hereinafter referred to as 'NMD') and an artificially controlled NMD using the same. Provide a method. Through the molecular biological understanding of NMD and artificial NMD efficiency control technology according to the present invention, it is possible to develop therapeutic agents or inhibitors of NMD-related genetic diseases and cancers. |
| priorityDate |
2008-05-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |